Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Quest Diagnostics Inc. (NYSE: DGX) shares jumped 5.55 percent to close at $57.99 a share Wednesday. The stock traded between $56.99 and $60.50 on volume 6.92million shares traded. The company announced that its Focus Diagnostics products business has received expedited FDA 510(k) clearance and CLIA moderate complexity categorization for its new Simplexa HSV 1 & 2 Direct molecular test. Shares of Quest Diagnostics are up approximately 8.0 percent year-to-date.
Get more information on Quest Diagnostics free access to the in-depth equity report at: www.FiveStarEquities.com/DGX
Exelixis, Inc. (NASDAQ: EXEL) shares tumbled 39.36 percent to close at $3.90 a share Wednesday. The stock traded between $3.87 and $4.50 on volume of 54.41 million shares traded. The company announced that independent data monitors have concluded that the phase III study of cabozantinib in advanced prostate cancer should proceed to its final analysis. Shares of Exelixis are down approximately 36.0 percent year-to-date.
Get more information on Exelixis and free access to the in-depth equity report at: www.FiveStarEquities.com/EXEL
Insmed Inc. (NASDAQ: INSM) shares dropped 13.09 percent to close at $15.90 a share Wednesday. The stock traded between $15.55 and $17.38 on volume of 7.81 million shares traded. The company announced that ARIKAYCE failed to meet its primary endpoint in a recent mid-stage study. Shares of Insmed are down approximately 6.0 percent year-to-date.
Get more information on Insmed and free access to the in-depth equity report at: www.FiveStarEquities.com/INSM
Steelcase Inc. (NYSE: SCS) shares spiked 11.66 percent to close at $16.28 a share Wednesday. The stock traded between $15.86 and $16.91 on volume 3.23 million shares traded. The company reported diluted earnings per share of $0.19 fourth quarter of 2013, compared to a diluted loss per share of $0.22 a year ago. Shares of Steelcase are up approximately 3.0 percent year-to-date.
Get more information on Steelcase and free access to the in-depth equity report at: www.FiveStarEquities.com/SCS
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]